Massachusetts marijuana regulators have unanimously approved rules to license and regulate cannabis social consumption lounges in the state.

Members of the Cannabis Control Commission (CCC) voted 4-0 on Thursday to approve the rule, which was unveiled over the summer.

The rules create three new license types related to social consumption: One would let existing dispensaries build upon their business by allowing marijuana use at their facilities, another would permit “hospitality” services by non-cannabis businesses such as cafes and theaters, and another would create an “event organizer” category for entities wishing to allow marijuana consumption at events such as music festivals.

“The Commonwealth has been eagerly waiting social consumption, so we're proud to move this effort across the finish line,” Shannon O'Brien, chair of the commission, said in a press release. “We look forward to the economic opportunities these new license types will offer to small businesses and entrepreneurs who have been disproportionately harmed by the War on Drugs.”

Bruce Stebbins, co-chair of the CCC social consumption working group, said the finalized regulatory package “reflects years of stakeholder engagement, research, and policy discussion and deliberation.”

“Next steps will include ongoing engagement with municipalities that must opt-in to hosting social consumption and educating residents to ensure the Commonwealth is prepared for this expansion of our $8 billion regulated cannabis industry,” he said.

The enactment of the policy makes Massachusetts the first state in New England to allow cannabis social consumption facilities to open.

Today Commissioners voted unanimously to approve three new license types that will allow the on-site consumption of cannabis in Massachusetts for the first time. Learn about the final policies and next steps here: https://t.co/tsE2Wlggtb

— Massachusetts Cannabis Control Commission (@MA_Cannabis) December 11, 2025

Kimberly Roy, another member of the commission, said the vote to advance the package “marks a long-awaited and carefully considered milestone for Massachusetts' regulated cannabis industry.”

“By finalizing the Social Consumption license-type, the Commission is honoring the will of the voters who envisioned safe, legal spaces for adult-use cannabis, while maintaining strong safeguards to protect public health and public safety,” she said. “This achievement represents years of collaboration among stakeholders, policymakers, and communities across the Commonwealth.”

However, she added, the vote on Thursday “does not conclude the Commission's work; it begins a new chapter of consumer and public education to ensure this emerging sector operates safely and responsibly.”

Commissioner Carrie Benedon said the “finalization of these social consumption reforms represents a significant milestone for legal cannabis in the Commonwealth.”

“Commissioners and staff have put significant thought and care into crafting a program that will provide economic opportunities for equity participants and small businesses while emphasizing public health and safety,” she said.

Travis Ahern, executive director of CCC, said the social consumption license option “offers the Commonwealth significant regional tourism opportunities, safe spaces for those who cannot consume cannabis at home, the ongoing transition of legacy operators to the legal market,” he said. “Commission staff have worked hard to support the creation of each license type, and we're excited to get to work setting up the internal infrastructure that will enable these new businesses to serve Massachusetts residents.”

The policy change around social consumption lounges comes amid a push by anti-legalization activists to put an initiative on the ballot next year that would roll back the state's adult-use legalization law.

An association of Massachusetts marijuana businesses recently urged voters to tell local officials about any cases of misleading signature gathering tactics and “fraudulent messaging” by the campaign behind that effort.

There have been allegations piling up that petitioners working on behalf of Coalition for a Healthy Massachusetts have shared false information about what the measure would accomplish, with claims that paid petitioners have used fake cover letters for other ballot measures on issues like affordable housing and same-day voter registration. The state attorney general's office has confirmed that it has received complaints to that effect, but the campaign has denied sanctioning such activities.

Under the proposed initiative, adults 21 and older could still possess up to an ounce of cannabis, only five grams of which could be a marijuana concentrate product. Possession of more than one ounce but less than two ounces would be effectively decriminalized, with violators subject to a $100 fine. Adults could also continue to gift cannabis to each other without remuneration.

But provisions in the state's voter-approved marijuana law that allow for commercial cannabis retailers and access to regulated products by adults would be repealed under the proposal. Adults' right to cultivate cannabis at home would also be repealed. The medical cannabis program would remain intact, however.

Massachusetts Attorney General Andrea Campbell's (D) office—which cleared the campaign for signature gathering in September—has stressed to voters the importance of reading their summary, which is required to go at the top of the signature form, before signing any petitions.

Meanwhile, the head of Massachusetts's marijuana regulatory agency recently suggested that the measure to effectively recriminalize recreational cannabis sales could imperil tax revenue that's being used to support substance misuse treatment efforts and other public programs.

Whether the cannabis measures will be approved is yet to be seen. Voters approved legalization at the ballot in 2016, with sales launching two years later. Over the past decade, the market has evolved and expanded. As of August, Massachusetts officials reported more than $8 billion in adult-use marijuana sales.

In November, the Massachusetts Senate approved a bill that would double the legal marijuana possession limit for adults and revise the regulatory framework for the state's adult-use cannabis market. Similar legislation also advanced through the House earlier this year.

---

Written by Kyle Jaeger for Marijuana Moment | Featured image by Gina Coleman/Weedmaps

The post Massachusetts Officials Approve Rules Allowing Marijuana Social Consumption Lounges To Open appeared first on Weedmaps News.

President Donald Trump is expected to issue an executive order rescheduling marijuana and covering certain CBD treatments under Medicare.

Trump marijuana rescheduling, CBD coverage order expected Monday is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

President Donald Trump could issue an executive order reclassifying marijuana as a less dangerous drug as soon as Monday, multiple sources told MJBizDaily.

And along with moving cannabis to Schedule 3, unlocking major tax breaks for plant-touching businesses, the president may also hand the CBD industry a significant gift: allowing Medicare insurance coverage for certain CBD treatments, sources said.

ADVERTISEMENT

That timeline is consistent with reporting from CNBC, which said Friday the president “is expected” to order cannabis moved to Schedule 3 of the Controlled Substances Act at the beginning of next week.

The presidential executive order is not yet finalized, cautioned the sources, who agreed to speak on condition of anonymity. Thus, it’s not clear exactly how long the Trump marijuana rescheduling process

The post Trump marijuana rescheduling expected Monday along with coverage for CBD appeared first on GrowCola.com.

President Donald Trump is weighing an executive order that would push the federal government to reclassify cannabis, a step that could mark the most significant shift in U.S. cannabis policy in decades—even as the White House cautions that no final decision has been made.

The deliberations, first reported late Thursday by The Washington Post, center on moving marijuana from Schedule I—the government’s most restrictive category, reserved for drugs deemed to have no accepted medical use—to Schedule III, a classification that would acknowledge medical value and loosen some federal controls. 

“This is an encouraging development and a strong indicator that comprehensive legalization is no longer a distant goal,” says Sorse Tech CEO Howard Lee.

The Post reported Trump discussed the potential policy change in a call that included House Speaker Mike Johnson and cannabis industry executives, alongside senior administration officials. Johnson voiced skepticism, the report said, while industry participants pressed the case that rescheduling would reduce barriers to research and help normalize a legal market that now operates in tension with federal law. 

In response to the news, Sasha Nutgent, VP of cannabis retail for Housing Works Cannabis Co. out of New York, tells Cannabis Now that with today’s current cannabis classification, “retailers are not incentivized to operate legally. Reclassification would change that for thousands of businesses, especially those owned by folks from communities most impacted by the War on Drugs.”

Industry and Markets Brace for Potential Policy Change

News of the possible executive order rippled quickly through financial markets early this morning. Cannabis-related stocks and exchange-traded funds jumped in premarket trading after the Post report, according to Reuters, reflecting investor optimism that a federal shift could ease access to capital and reduce tax burdens that have long squeezed state-legal operators. 

Rescheduling, however, would not legalize marijuana nationwide. Even supporters describe it as a narrower, technical move with broad downstream effects—especially for research, medical access and business operations—rather than a sweeping rewrite of prohibition-era policy. 

Gennaro Luce, founder and CEO at CannaLnx, powered by EM2P2, argues that “Rescheduling is an important and overdue shift for patient-centric healthcare, but the move to Schedule III alone isn’t enough to make medical cannabis more accessible or affordable.”

Luce says insurers still need verification, compliance and eligibility frameworks before they can treat medical cannabis like a real benefit. “That part of the system is still missing from the national conversation — fortunately, it’s the medical-cannabis system piece we’ve already built and tested alongside physicians, patients, dispensaries, POS systems and insurers.”

Legal Nuances Stall Progress

President Trump’s considerations land on well-trodden terrain. The modern push to reconsider cannabis’ federal classification accelerated under President Joe Biden, whose administration initiated a review that produced a recommendation from the Department of Health and Human Services to move cannabis to Schedule III. The Justice Department formally began the rescheduling process in 2024, opening the door to rulemaking that has since faced delays and political crosscurrents. 

Policy experts say an executive order can direct agencies and set priorities, but it cannot, by itself, rewrite the Controlled Substances Act. Any durable change to cannabis scheduling ultimately runs through federal administrative procedures led by the Justice Department and the Drug Enforcement Administration, including scientific findings, legal analysis and formal rulemaking steps. That legal nuance has become familiar to cannabis readers—and to anyone who has watched the issue ricochet between campaign promises and bureaucratic reality.

In past coverage of cannabis executive action, Cannabis Now has emphasized that the “stroke of a pen” theory often collides with the limits of federal authority, even when presidents or governors have wide latitude to shape enforcement priorities and regulatory posture. Still, the political stakes are unmistakable. A Trump-backed push to reschedule could scramble the usual partisan map on cannabis, where national Democrats have often positioned themselves as the party of reform while Republicans have been divided between states’-rights advocates and prohibition-aligned lawmakers.

The Post report suggested Trump views rescheduling as a way to “cut restrictions” without endorsing full legalization—a framing that could appeal to voters who support medical access and regulated markets but remain cautious about broader social change. 

For the cannabis industry, the practical implications of Schedule III are potentially enormous—but also uneven. Operators have argued that rescheduling could reduce certain federal tax penalties and make it easier for institutions to do business with cannabis companies.

Ryan Hunter, chief revenue officer for Colorado-based Spherex, a leader in cannabis extraction and purification, offers perspective: “Cannabis is still federally illegal—but even as a federally illegal substance, the move to Schedule III dramatically reduces the federal tax burden for operators. Under IRS code 280E, handling Schedule I or Schedule II substances eliminates the ability for operators to deduct standard operating expenses that most other businesses deduct from their federal taxes. As a result of 280E, cannabis operators’ effective tax rate may be as high as 80 pecent. Beyond this significant improvement, the implications are unclear, but we’re hopeful that this move will allow for cannabis operators to garner the same investment opportunities other industries will enjoy.”

Rescheduling’s Promise and Uncertainty

Analysts told Reuters that shifting cannabis to Schedule III could also accelerate pharmaceutical research and distribution models, even as state-legal markets continue to rely on a patchwork of rules that vary widely from one jurisdiction to another. Critics, including some in Congress, argue rescheduling risks moving faster than the science. The Post reported Johnson referenced studies he said cut against reclassification, reflecting a broader debate over how to weigh evidence of therapeutic benefits against risks of misuse and dependency. 

What happens next could hinge on timing and follow-through. An executive order, if issued, would likely instruct cabinet agencies to prioritize or expedite the administrative process rather than instantly change marijuana’s legal status. Even then, opponents could challenge the move politically and in court, while regulators would still need to align policy with existing federal statutes and international commitments.

“Whenever the White House moves forward with Schedule III, the federal government is effectively telling us that cannabis is medicine,” comments Calyx Containers President and Co-Founder Alex Gonzalez. “And if it’s medicine, ‘good enough’ cannabis practices won’t cut it anymore. Whether rescheduling happens next month or next year, the direction is clear: Cannabis is moving toward pharma-grade standards. For brands, that means tightening quality systems, investing in the ability to react or scale, and preparing for a regulatory-ready supply chain. We’re seeing the smart operators onshoring infrastructure, and we’re positioning our domestic production and business model on being ready to help operators turn this moment into a competitive advantage.”

In the meantime, the national reality on cannabis continues to diverge from federal law. Most states now allow marijuana for medical use, and a growing number permit adult-use sales—a shift that has normalized cannabis commerce for millions of Americans while leaving businesses and consumers navigating legal gray zones that are invisible at the dispensary counter but very real at banks, research institutions and federal agencies.

“Rescheduling is the single most important drug policy move in decades. The potential opportunities for medical and scientific research will significantly increase, while those living in states without an existing medical program will now have access to the powerful healing properties of the plant,” says Mark Lewis, president of specialty banking at Lüt.

“Make no mistake though, rescheduling is just the beginning for those working in the cannabis industry. Until the SAFE Banking Act or 280E is passed, operators will still have to jump through challenging financial hoops to pay their staff, bills or garner investment. The moment is historic, but until cannabis businesses can operate fiscally with the same ease as any other business, more work needs to be done,” Lewis continued. “Payments still need to work in the reality of today, where the ongoing threat of card network shutdowns exists, not just the promise of future reform. While rescheduling may open doors over time, it does not remove the day-to-day financial friction that cannabis operators face right now.”

Whether Trump ultimately signs an order or backs away, the past 24 hours have underscored a core truth of cannabis politics in Washington: Even incremental change can move markets, reshape messaging and reopen debates that Congress has struggled for years to settle.

The post Trump Weighs Executive Order to Advance Cannabis Rescheduling appeared first on Cannabis Now.

We asked Snoop three burning questions. Find out Snoop Dogg's favorite strain, and 2 more hot takes from the legend.

The post Snoop Dogg’s favorite strain, and 2 more essential takes from our interview appeared first on Leafly.

Bipartisan congressional lawmakers are weighing in on a potentially imminent decision by President Donald Trump to move forward with federal marijuana rescheduling—with Democrats like Rep. Alex Ocasio-Cortez (D-NY) calling the reform a “no-brainer” and others like Rep. Andy Harris (R-MD) pushing back against the proposal.

It was first reported on Thursday that Trump intended to sign an executive order on rescheduling, potentially directing the attorney general to complete the Biden administration-initiated process to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA).

Since then, a number of lawmakers on both sides of the aisle have shared their views on the plan in interviews with Marijuana Moment. While Democrats might disagree with the president on a multitude of policy issues, they’ve generally welcomed the news about the rescheduling development, even if they’d ultimately like to see a complete end to federal prohibition rather than the incremental change.

Ocasio-Cortez said it’s a “no-brainer” to enact the policy change, which would federally legalize marijuana but would remove certain research barriers and let cannabis businesses take federal tax deduction, while symbolically recognizing the medical value of the plant.

“I’ve honestly felt that it’s been a race” between the two

The post Bipartisan Congressional Lawmakers Give Mixed Reactions To Marijuana Rescheduling News From Trump Administration appeared first on GrowCola.com.

After years of delays, Alabama is finally making progress on launching medical marijuana sales.

The Alabama Medical Cannabis Commission (AMCC) on Thursday unanimously approved dispensaries licenses for three companies: GP6 Wellness, RJK and CCS of Alabama, according to WVTM 13.

ADVERTISEMENT

The award of the fourth dispensary license available under state law is on hold for 46 days, but could be awarded in January, according to Al.com.

The first three MMJ dispensaries could be licensed by Jan. 8, more than two years after licenses were granted to cultivators and transporters. Cultivators have already harvested several crops.

When the licenses are issued, doctors can start recommending medical marijuana to their patients.

The first sale could then come by the spring, AMCC Chair Rex Vaughn said,

The post Alabama finally awards medical marijuana dispensary permits appeared first on GrowCola.com.

After years of waiting, Alabama is finally making progress on making medical marijuana available to patients in the state.

Alabama finally awards medical marijuana dispensary permits is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Wanda James, a marijuana dispensary owner and advocate in Colorado who’s running for Congress, is applauding news about a potentially imminent move by the Trump administration to federally reschedule cannabis. But that reform doesn’t go far enough, she said, pledging to introduce a bill to end prohibition altogether on her “first day” on Capitol Hill if she’s elected.

To help her accomplish that goal, James has hired Neal Levine—a decades-long veteran of the cannabis reform movement—to manage her campaign, Marijuana Moment has exclusively learned.

As one of the first Black dispensary owners in the country, the candidate said in a statement on Thursday that she welcomes reports that President Donald Trump would be making a final decision on moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA).

Whether or when that happens remains unclear, and a White House spokesperson told Marijuana Moment that “no final decisions have been made” at this point.

In any case, James said that any incremental reform that “reduces barriers for research, protects patients, or eases access for workers and businesses is welcome.” However, “Coloradans and all Americans, deserve more than halfway measures that leave core issues of justice, equity, and

The post As Trump Nears Marijuana Announcement, Dispensary Owner Running For Congress Pledges To File Full Legalization Bill On First Day In Office appeared first on GrowCola.com.

An Alaska campaign says it failed to collect enough signatures to put an initiative to legalize certain psychedelics such as psilocybin and DMT on the state’s 2026 ballot—but activists are emphasizing that the “work is far from over” as they shift focus to placing the reform measure before voters in 2028.

About three months after state officials cleared Natural Medicine Alaska to collect signatures for the initiative, the campaign announced on Wednesday that, “despite months of tireless work,” they were “unable to gather enough signatures to place the Alaska Natural Medicine Act on the 2026 ballot.”

“Throughout this effort, we submitted initial signatures, mobilized volunteers across Anchorage, the Valley, the Kenai Peninsula, Haines, Juneau, and communities statewide, and built strong grassroots momentum,” it said. “Even with these tremendous efforts, we have determined that we will not reach the full signature threshold to qualify the Alaska Natural Medicine Act for the 2026 ballot.”

A spokesperson for the campaign told Marijuana Moment on Wednesday that organizers collected more than 10,000 signatures during the relatively short window to qualify the initiative for next year. But they won’t have to start over again to make the ballot in 2028, as those petitions will still

The post Alaska Psychedelics Campaign Ends Push To Put Legalization On 2026 Ballot, Shifting Focus To 2028 appeared first on GrowCola.com.

Cereal Killa Feminized wasn’t quite what we’d expected. With a predominantly indica lineage, this strain’s lanky, stretched-out frame, delayed flowering time, and smallish flower clusters are distinctly sativa-like. On the other hand, the rapid development of the buds once started, their density, and their sedative effects are classically indica.

The post Cereal Killa Feminized Grow Report appeared first on Sensi Seeds.

States that opened recreational marijuana dispensaries saw suicide rates decline among older adults, according to a new scientific analysis of more than two decades of nationwide data. Correlating state legalization to the decline, the researchers note a “modest yet statistically significant reduction” in states with legal access to cannabis.

The research, conducted by a team of public health economists, examined monthly suicide counts from U.S. states between 2000 and 2022. Their aim was to better understand whether easier access to marijuana, specifically through licensed retail stores, might have any measurable effect on mental health outcomes. Their working paper, published by the National Bureau of Economic Research, shows that may be the case.

The study found that in states where recreational cannabis dispensaries began operating, suicide rates among adults ages 45 and older declined. The effect was strongest among men, who historically have had significantly higher suicide rates and are more likely to use cannabis to manage chronic pain, a health challenge that increases the risk of suicide.

“Given that older adults are more prone to chronic pain and various physical and mental health issues, it is not surprising that this demographic is increasingly turning to marijuana for its medicinal properties,”

The post Legal Marijuana Access Reduces Suicide Rates For Older Adults, New Study Suggests appeared first on GrowCola.com.

 

 

Why Growers Are Getting Double Seeds Without Paying More

 

Growers love value.

 

However, they love it even more when it feels simple.

 

Right now, many growers are getting double the seeds without paying more.
This is not a trick or a limited loophole.  Instead, it comes from smart offers that stack together.

 

Because buy one get one free deals run alongside free seed rewards, value adds up fast.

As a result, one order can unlock far more seeds than expected.
Best of all, everything happens automatically.

 

So, if you want more genetics for the same spend, you are in the right place.
Let’s break down how growers are making it work.

 

Barneys Farm Buy One Get One Free – Feminised Packs

 

First, Barneys Farm leads with trusted genetics.

 

Growers around the world rely on their strains.

 

Right now, selected packs come with buy one get one free.

 

Although discount codes do not apply, the value stays strong.

 

You pay once and receive double the seeds.

 

As a result, each pack goes further.

 

Because of this, these offers suit home growers.

 

They also suit strain collectors.

 

Overall, they deliver easy, reliable value.

 

 

Barneys Farm Buy One Get One Free Strains

 

This selection blends classic favourites with modern hits.

 

It also covers both 5 packs and 10 packs.

 

That means more choice without confusion.

 

5 pack of Barneys Farm Seeds – Buy one get one FREE

 

 

Acapulco Gold, Glookies, Mendo Breath, Moby Dick, Purple Punch,
Purple Punch x Lemon Drizzle, RS11 x Banana OG,
Runtz x Layer Cake, Sour Diesel, Sour Strawberry,
Trainwreck, and Zoap.

 

10 pack of Barneys Farm Seeds – Buy one get one FREE

 

 

Biscotti, Blue Cheese, Cookie Casket, Laughing Buddha,
Mendo Breath, RS11 x Banana OG, Sour Diesel,
Tropicanna Banana, and Zoap.

 

As a result, the range feels balanced and flexible.

 

Nothing feels overwhelming.

 

Everything feels useful and easy to choose.

 

Seedstockers Buy One Get One Free – 25 Seed Packs

 

 

Next, Seedstockers focuses on volume and value.

 

Selected 25 seed packs include 25 free seeds.

 

You receive 50 seeds in total.

 

Because of this, larger grows cost less.

 

At the same time, planning becomes easier.

 

More seeds give more freedom.

 

All Seedstockers 25 pack strains are available on BOGOF.

 

This range covers proven favourites.

 

White Widow stays reliable.

 

Northern Lights grows with ease.

 

Meanwhile, Bruce Banner adds strength.

 

Gorilla Cookies adds rich flavour.

 

In fact, there are too many strains to list here.

 

The selection covers a wide mix of styles and flavours.

 

You will also find a strong mix of feminised and autoflowering options.

 

Because of this, Seedstockers offers something for every grow style.

 

From fast autos to proven classics, choice stays wide.

 

Check the full Seedstockers range to see all the goodies available.

 

 

Free Seeds When You Spend More

 

 

Free seeds add themselves to your order.

Spend £100 and gain extra seeds.

You also receive a Dutch Passion seed pack.

 

Spend £150 and rewards increase further.

You gain nine extra premium seeds.

You do not need a code.

 

 

All Free Seed Offers Stack Automatically

 

 

This part matters most.

All free seed offers stack together.

Nothing replaces anything else.

For example, a £150 order gives sixteen free seeds.

At the same time, BOGOF packs still apply.

So, value builds very fast.

 

Super Special Offers – Up to 50% Off

 

 

Some packs carry heavy discounts.

 

Savings reach up to fifty percent.

 

Discount codes do not apply here.

 

Still, prices already sit low.

 

In addition, forty-five new strains joined the range.
Because stock moves fast, timing matters.

 

Using Discount Codes – What to Know

 

 

Christmas10 gives 10% off.

 

You can use it on seeds, headshop items, and CBD.
Some exclusions apply.

 

Barneys Farm BOGOF packs do not accept codes.

 

Super Special Offers do not either.

 

Even so, free seeds still stack.

 

Choose Your Way and Get More Seeds

 

 

In short, value suits every grower.

 

Small orders gain extra seeds.

 

Large orders unlock serious volume.

 

Because everything stacks, saving feels easy.

 

Therefore, choosing your way makes sense.

 

Now is the time to grow more for less.

 

 

 

Promos, Discounts and Free Seeds at The Vault

 

Discover unbeatable value with our discount cannabis seeds, where premium genetics meet wallet-friendly prices, giving you access to top-tier strains without the premium cost.

 

Our promotions are about helping you stretch your budget further while still enjoying high-quality, reliable genetics—perfect for growers who want maximum results with minimal spend. From beginner-friendly varieties to elite, high-performing strains, our discount cannabis seeds make it easier than ever to explore new options, stock up, and grow more for less.

 

Our offers page is packed with rotating Discounts, exclusive On Purchase Promos, Super Special Offers and generous FREE Seeds.

 

You’ll also find exciting competitions and giveaways designed to help you grow more for less, with chances to win everything from premium cannabis seeds to top-quality CBD products and must-have headshop gear.

 

Whether you’re stocking up or trying something new, you’ll find top-quality strains at reduced prices alongside bonus deals you won’t want to miss. Dive in and level up your grow while keeping costs low — smart shopping never felt so rewarding.

 

Newsletter Sign Up

 

Finally, to stay fully in the loop with all the latest Vault deals, giveaways, promos, and exclusive offers, make sure you join our newsletter to be notified the moment new updates drop.

 

It’s the easiest way to get insider info delivered straight to your inbox, including early-access promotions, special competitions, and new discount cannabis seed releases.

 

Don’t miss out — stay connected and always be the first to know what’s coming next.

 

Remember: It is illegal to germinate cannabis seeds in many countries including the UK. It is our duty to inform you of this fact and to urge you to obey all of your local laws to the letter. The Vault only ever sells or sends out seeds for souvenir, collection or novelty purposes.

 

 

The post Why Growers Are Getting Double Seeds Without Paying More first appeared on Cannabis Seeds News.

Returning to classic strains isn't about nostalgia - it's about building a scalable cannabis market.

Blue Dream’s revenge: Why the market needs old-school cannabis genetics is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Michael Kudrewicz/Courtesy photo

(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.)

As legalization continues to spread and regulated cannabis markets mature, a critical vulnerability is appearing at a fundamental link on the supply chain: unstable, poorly sourced genetics.

In the push for new strains that look different, sound different, or test at higher levels of THC, the $32 billion legal cannabis industry has drifted away from reliable cultivars. Yet the more we scale, the more it becomes clear that the future of cannabis hinges on heritage genetics.

ADVERTISEMENT

Legacy cultivars – the Blue Dreams, Trainwrecks, and Sour Diesels fondly remembered from the legacy market and early-stage medical cannabis era – provide a foundation that many modern

The post Blue Dream’s revenge: Why the market needs old-school cannabis genetics appeared first on GrowCola.com.

SCOTUS marijuana meeting; OH gov to sign cannabis restrictions; KY medical marijuana sales launch; ID ballot; FM DEA official on cartel/legalization

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Your support makes Marijuana Moment possible…

Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on.

Check us out on Patreon and sign up to give $25/month today:
https://www.patreon.com/marijuanamoment

/ TOP THINGS TO KNOW

Prohibitionist group Smart Approaches to Marijuana is warning that President Donald Trump may be about to imminently announce his administration will reschedule cannabis—but a White House spokesperson tells Marijuana Moment that “no final decisions have been made.”

U.S. Supreme Court justices are set to discuss whether to take up a case from marijuana businesses that are challenging the constitutionality of federal prohibition in a

The post Trump rescheduling cannabis imminently? (Newsletter: December 12, 2025) appeared first on GrowCola.com.

It has been almost a week since MJBizCon concluded.  This week continues to be an annual pilgrimage for many (including myself) to seek ongoing networking and relationship building, as well as what more this industry can offer.  Each year, I am blown away by the creativity and innovation that I witness at this event.  There […]

The post MJBizCon 2025 Recap and Event Highlights appeared first on The Weed Blog.

President Donald Trump is expected to issue an executive order reclassifying cannabis under federal law, the Washington Post reported on Thursday.

Report: President Trump close to marijuana rescheduling is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

President Donald Trump could soon direct the federal government to reclassify cannabis as a less dangerous drug, the Washington Post reported late Thursday.

Echoing a similar Biden-era directive to ease restrictions, Trump is weighing an executive order that would direct federal agencies to move marijuana to Schedule 3 of the federal Controlled Substances Act, according to the Post, which cited six unnamed sources with knowledge of a discussion between the president and Republican House Speaker Mike Johnson.

ADVERTISEMENT

The timing is unclear – as is the president’s commitment.

Trump, who over the summer promised to look at marijuana rescheduling within a few weeks, “could still change his mind,” according to the Post’s sources, who added that the exact plan isn’t yet finalized.

But if

The post Report: President Trump close to marijuana rescheduling appeared first on GrowCola.com.

A leading prohibitionist group is sounding the alarm about a potentially imminent decision from the Trump administration to reschedule marijuana, and a major news organization is reporting that the president plans to issue an executive order on the policy change—but despite amplified rumors about the potential reform action, the White House tells Marijuana Moment that “no final decisions have been made.”

There’s been a swell of speculation in recent days from industry observers, as well as opponents of rescheduling such as Smart Approaches To Marijuana (SAM), that President Donald Trump would be making a decision on moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) as early as Thursday or Friday.

Those rumors became so pronounced that Kevin Sabet, president of the prohibitionist group SAM, took to X to share a video about the issue.

“If the rumors are correct,” Sabet said, “President Trump is going to call for marijuana to be rescheduled to Schedule III,” which is “obviously not an outcome we wanted.”

“But I can tell you that it’s not going to be good for our country for many reasons,” he said. “First of all, it’s going to give tax breaks to big

The post Trump May Be About To Announce He’s Reclassifying Marijuana, Opponents Warn As White House Denies Rumors appeared first on GrowCola.com.